Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             271 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: Results of a randomised, controlled, dose-escalation phase 1 trial Richmond, P.C.
2012
30 Supplement 1 p. 6163-6174
12 p.
artikel
2 Acceptability of human papillomavirus vaccination and sexual experience prior to disclosure to health care providers among men who have sex with men in Vancouver, Canada: Implications for targeted vaccination programs Rank, Claudia
2012
30 Supplement 1 p. 5755-5760
6 p.
artikel
3 A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination Sabarth, Nicolas
2012
30 Supplement 1 p. 5533-5540
8 p.
artikel
4 A cluster of nonspecific adverse events in a military reserve unit following pandemic influenza A (H1N1) 2009 vaccination—Possible stimulated reporting? McNeil, Michael M.
2012
30 Supplement 1 p. 2421-2426
6 p.
artikel
5 A collaborative approach to investigating the risk of thrombocytopenic purpura after measles–mumps–rubella vaccination in England and Denmark Andrews, Nick
2012
30 Supplement 1 p. 3042-3046
5 p.
artikel
6 Acute exercise enhancement of pneumococcal vaccination response: A randomised controlled trial of weaker and stronger immune response Edwards, Kate M.
2012
30 Supplement 1 p. 6389-6395
7 p.
artikel
7 A designed Tat immunogen generates enhanced anti-Tat C-terminal antibodies Liao, Wenting
2012
30 Supplement 1 p. 2453-2461
9 p.
artikel
8 Adjuvant effect of Japanese herbal medicines on the mucosal type 1 immune responses to human papillomavirus (HPV) E7 in mice immunized orally with Lactobacillus-based therapeutic HPV vaccine in a synergistic manner Taguchi, Ayumi
2012
30 Supplement 1 p. 5368-5372
5 p.
artikel
9 A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children Anh, Dang Duc
2012
30 Supplement 1 p. A114-A121
nvt p.
artikel
10 Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010 Ouandaogo, Claude-Roger
2012
30 Supplement 1 p. B46-B51
nvt p.
artikel
11 Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) enhanced inflammatory cytokine productions Nakayama, Tetsuo
2012
30 Supplement 1 p. 3885-3890
6 p.
artikel
12 An engineered mutant of HIV-1 gp120 formulated with adjuvant Quil A promotes elicitation of antibody responses overlapping the CD4-binding site Ahmed, Fatima K.
2012
30 Supplement 1 p. 922-930
9 p.
artikel
13 An HIVgp41 vaccine protects CD4 central memory T cells in SHIV-infected macaques Vieillard, Vincent
2012
30 Supplement 1 p. 6883-6891
9 p.
artikel
14 An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP–IPV (Kinrix™) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children Klein, Nicola P.
2012
30 Supplement 1 p. 668-674
7 p.
artikel
15 A novel adjuvant, mixture of alum and the beta-adrenergic receptor antagonist propranolol, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccine Mazloomi, Ebrahim
2012
30 Supplement 1 p. 2640-2646
7 p.
artikel
16 A novel self-assembled nanoparticle vaccine with HIV-1 Tat49-57/HPV16 E749-57 fusion peptide and GM-CSF DNA elicits potent and prolonged CD8+ T cell-dependent anti-tumor immunity in mice Tang, Jun
2012
30 Supplement 1 p. 1071-1082
12 p.
artikel
17 Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA) Shibl, Atef M.
2012
30 Supplement 1 p. G32-G36
nvt p.
artikel
18 Antibody response to allelic variants of 19kDa fragment of MSP-1: Recognition of a variant and protection associated with ethnicity in Assam, India Lourembam, Sonia D.
2012
30 Supplement 1 p. 767-773
7 p.
artikel
19 An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young women Jacobsen, Steven J.
2012
30 Supplement 1 p. 4585-4587
3 p.
artikel
20 An update on human papillomavirus vaccine uptake among 11–17 year old girls in the United States: National Health Interview Survey, 2010 Laz, Tabassum H.
2012
30 Supplement 1 p. 3534-3540
7 p.
artikel
21 A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome Boudreau, Ellen F.
2012
30 Supplement 1 p. 1951-1958
8 p.
artikel
22 A phase 3, randomized, double-blind trial comparing the safety and immunogenicity of the 7-valent and 13-valent pneumococcal conjugate vaccines, given with routine pediatric vaccinations, in healthy infants in Brazil Weckx, Lily Yin
2012
30 Supplement 1 p. 7566-7572
7 p.
artikel
23 A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women Sun, Kui-Xia
2012
30 Supplement 1 p. 5335-5340
6 p.
artikel
24 A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations Hatz, Christoph
2012
30 Supplement 1 p. 4820-4827
8 p.
artikel
25 A retrospective epidemiological study of invasive pneumococcal infections in children aged 0–5 years in Bahrain from 1 January 1999 to 31 December 2003 Al Musawi, Muna
2012
30 Supplement 1 p. G2-G6
nvt p.
artikel
26 Ascaris suum enolase is a potential vaccine candidate against ascariasis Chen, Ning
2012
30 Supplement 1 p. 3478-3482
5 p.
artikel
27 A single-dose cytomegalovirus-based vaccine encoding tetanus toxin fragment C induces sustained levels of protective tetanus toxin antibodies in mice Tierney, Rob
2012
30 Supplement 1 p. 3047-3052
6 p.
artikel
28 Assessing the immunological response to hepatitis B vaccination in HIV-infected patients in clinical practice Mena, Guillermo
2012
30 Supplement 1 p. 3703-3709
7 p.
artikel
29 Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs Sanford, Brenton J.
2012
30 Supplement 1 p. 6249-6255
7 p.
artikel
30 Association of polymorphisms of cytokine and TLR-2 genes with long-term immunity to hepatitis B in children vaccinated early in life Wang, Yangyang
2012
30 Supplement 1 p. 5708-5713
6 p.
artikel
31 A strategy of antigen incorporation into exosomes: Comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particles Lattanzi, Laura
2012
30 Supplement 1 p. 7229-7237
9 p.
artikel
32 A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009–2010 season Tennis, Patricia
2012
30 Supplement 1 p. 6099-6102
4 p.
artikel
33 Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review Isai, Alina
2012
30 Supplement 1 p. 7123-7129
7 p.
artikel
34 A varicella outbreak in a school with high one-dose vaccination coverage, Beijing, China Lu, Li
2012
30 Supplement 1 p. 5094-5098
5 p.
artikel
35 Avian paramyxovirus serotypes 2-9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1) Nayak, Baibaswata
2012
30 Supplement 1 p. 2220-2227
8 p.
artikel
36 Avian reovirus sigma C enhances the mucosal and systemic immune responses elicited by antigen-conjugated lactic acid bacteria Lin, Kuan-Hsun
2012
30 Supplement 1 p. 5019-5029
11 p.
artikel
37 Barriers to HPV immunization for African American adolescent females Hamlish, Tamara
2012
30 Supplement 1 p. 6472-6476
5 p.
artikel
38 Baseline hepatitis B vaccination coverage among persons with diabetes before implementing a U.S. recommendation for vaccination Byrd, Kathy K.
2012
30 Supplement 1 p. 3376-3382
7 p.
artikel
39 Blockade of B7-H1 enhances dendritic cell-mediated T cell response and antiviral immunity in HBV transgenic mice Jiang, Wenzheng
2012
30 Supplement 1 p. 758-766
9 p.
artikel
40 Bovine tuberculosis vaccine research: Historical perspectives and recent advances Waters, W. Ray
2012
30 Supplement 1 p. 2611-2622
12 p.
artikel
41 Broad HIV-1 neutralizing antibody response induced by heterologous gp140/gp145 DNA prime-vaccinia boost immunization Liu, Lianxing
2012
30 Supplement 1 p. 4135-4143
9 p.
artikel
42 Canine rabies vaccination and domestic dog population characteristics in the developing world: A systematic review Davlin, Stacy L.
2012
30 Supplement 1 p. 3492-3502
11 p.
artikel
43 Capsule null locus meningococci: Typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine Claus, Heike
2012
30 Supplement 1 p. 155-160
6 p.
artikel
44 Cationic liposome–DNA complexes (CLDC) adjuvant enhances the immunogenicity and cross-protective efficacy of a pre-pandemic influenza A H5N1 vaccine in mice Dong, Libo
2012
30 Supplement 1 p. 254-264
11 p.
artikel
45 Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: Homologous or heterologous booster response following two dose or single dose priming van der Velden, Maikel V.W.
2012
30 Supplement 1 p. 6127-6135
9 p.
artikel
46 Challenges in confirming a varicella outbreak in the two-dose vaccine era Mahamud, Abdirahman
2012
30 Supplement 1 p. 6935-6939
5 p.
artikel
47 Challenge with a hepatitis B vaccine in two cohorts of 4–7-year-old children primed with hexavalent vaccines: An open-label, randomised trial in Italy Zanetti, Alessandro
2012
30 Supplement 1 p. 5770-5775
6 p.
artikel
48 Changes in seroprevalence to hepatitis A in Victoria, Australia: A comparison of three time points Heywood, A.E.
2012
30 Supplement 1 p. 6020-6026
7 p.
artikel
49 Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine Elberse, Karin E.M.
2012
30 Supplement 1 p. 7644-7651
8 p.
artikel
50 Changing epidemiology of pediatric Streptococcus pneumoniae isolates before vaccine introduction in Casablanca (Morocco) Elmdaghri, Naima
2012
30 Supplement 1 p. G46-G50
nvt p.
artikel
51 Characterizing providers’ immunization communication practices during health supervision visits with vaccine-hesitant parents: A pilot study Opel, Douglas J.
2012
30 Supplement 1 p. 1269-1275
7 p.
artikel
52 Children with otitis media mount a pneumococcal serotype specific serum IgG and IgA response comparable to healthy controls after pneumococcal conjugate vaccination Menon, Vinay J.
2012
30 Supplement 1 p. 3136-3144
9 p.
artikel
53 Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheria Hirobe, Sachiko
2012
30 Supplement 1 p. 1847-1854
8 p.
artikel
54 Codon changed immobilization antigen (iAg), a potent DNA vaccine in fish against Cryptocaryon irritans infection Jose Priya, T.A.
2012
30 Supplement 1 p. 893-903
11 p.
artikel
55 Comparative immunogenicity and safety of different multivalent component pertussis vaccine formulations and a 5-component acellular pertussis vaccine in infants and toddlers: A randomized, controlled, open-label, multicenter study Chatterjee, Archana
2012
30 Supplement 1 p. 3360-3368
9 p.
artikel
56 Comparative seroepidemiology of pertussis, diphtheria and poliovirus antibodies in Singapore: Waning pertussis immunity in a highly immunized population and the need for adolescent booster doses Lai, F.Y.
2012
30 Supplement 1 p. 3566-3571
6 p.
artikel
57 Conservation of HIV-1 T cell epitopes across time and clades: Validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccine Levitz, Lauren
2012
30 Supplement 1 p. 7547-7560
14 p.
artikel
58 Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates Wen, Xiaobo
2012
30 Supplement 1 p. 6121-6126
6 p.
artikel
59 Cost-effectiveness of hepatitis A vaccination for adults in Belgium Luyten, Jeroen
2012
30 Supplement 1 p. 6070-6080
11 p.
artikel
60 Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands Meijboom, M.J.
2012
30 Supplement 1 p. 4691-4700
10 p.
artikel
61 Current epidemiology of rubella and congenital rubella syndrome in Australia: Progress towards elimination Song, Ning
2012
30 Supplement 1 p. 4073-4078
6 p.
artikel
62 Current issues with the immunization program in Japan: Can we fill the “vaccine gap”? Saitoh, Akihiko
2012
30 Supplement 1 p. 4752-4756
5 p.
artikel
63 Delivery of antigenic candidates by a DNA/MVA heterologous approach elicits effector CD8+T cell mediated immunity against Trypanosoma cruzi Gupta, Shivali
2012
30 Supplement 1 p. 7179-7186
8 p.
artikel
64 Design and immunological properties of Helicobacter pylori glycoconjugates based on a truncated lipopolysaccharide lacking Lewis antigen and comprising an α-1,6-glucan chain Altman, Eleonora
2012
30 Supplement 1 p. 7332-7341
10 p.
artikel
65 Differential effects of monophosphoryl lipid A and cytokine cocktail as maturation stimuli of immunogenic and tolerogenic dendritic cells for immunotherapy Raïch-Regué, Dàlia
2012
30 Supplement 1 p. 378-387
10 p.
artikel
66 Disability among US Army Veterans vaccinated against anthrax Sulsky, Sandra I.
2012
30 Supplement 1 p. 6150-6156
7 p.
artikel
67 Do income inequality and social capital associate with measles-containing vaccine coverage rate? Nagaoka, Kei
2012
30 Supplement 1 p. 7481-7488
8 p.
artikel
68 Early infection dynamics after experimental challenge with Mycobacterium avium subspecies paratuberculosis in calves reveal limited calf-to-calf transmission and no impact of Hsp70 vaccination Santema, Wiebren J.
2012
30 Supplement 1 p. 7032-7039
8 p.
artikel
69 Early-life and contemporaneous nutritional and environmental predictors of antibody response to vaccination in young Gambian adults Moore, Sophie E.
2012
30 Supplement 1 p. 4842-4848
7 p.
artikel
70 Economic analysis for evidence-based policy-making on a national immunization program: A case of rotavirus vaccine in Thailand Muangchana, Charung
2012
30 Supplement 1 p. 2839-2847
9 p.
artikel
71 Economic evaluation of vaccination programme of 7-valent pneumococcal conjugate vaccine to the birth cohort in Japan Hoshi, Shu-ling
2012
30 Supplement 1 p. 3320-3328
9 p.
artikel
72 Editorial Board 2012
30 Supplement 1 p. IFC-
1 p.
artikel
73 Editorial Board 2012
30 Supplement 1 p. CO2-
1 p.
artikel
74 Editorial Board 2012
30 Supplement 1 p. CO2-
1 p.
artikel
75 Editorial Board 2012
30 Supplement 1 p. CO2-
1 p.
artikel
76 Editorial Board/Aims and Scope 2012
30 Supplement 1 p. CO2-
1 p.
artikel
77 Editorial Board/Aims and Scope 2012
30 Supplement 1 p. CO2-
1 p.
artikel
78 Editorial Board/Aims and Scope 2012
30 Supplement 1 p. CO2-
1 p.
artikel
79 Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience Djingarey, Mamoudou H.
2012
30 Supplement 1 p. B40-B45
nvt p.
artikel
80 Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: A model-based evaluation Fisman, David N.
2012
30 Supplement 1 p. 7601-7607
7 p.
artikel
81 Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: A case–control study Muangchana, Charung
2012
30 Supplement 1 p. 361-367
7 p.
artikel
82 Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza Örtqvist, Åke
2012
30 Supplement 1 p. 5699-5702
4 p.
artikel
83 Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users Tran, Thanh Q.
2012
30 Supplement 1 p. 342-349
8 p.
artikel
84 Effect of needle length for response to hepatitis B vaccine in macrosomic neonates: A prospective randomized study Ozdemir, Ramazan
2012
30 Supplement 1 p. 3155-3158
4 p.
artikel
85 Effect of vaccination with an inactivated vaccine on transplacental transmission of BTV-8 in mid term pregnant ewes and heifers van der Sluijs, M.T.W.
2012
30 Supplement 1 p. 647-655
9 p.
artikel
86 Effects of immunization with natural and recombinant lysine decarboxylase on canine gingivitis development Peters, Jennifer L.
2012
30 Supplement 1 p. 6706-6712
7 p.
artikel
87 Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: A randomized, double-blind, placebo-controlled trial Madhi, S.A.
2012
30 Supplement 1 p. A44-A51
nvt p.
artikel
88 Efficacy of a reformulated inactivated chimeric PCV1-2 vaccine based on clinical, virological, pathological and immunological examination under field conditions Seo, Hwi Won
2012
30 Supplement 1 p. 6671-6677
7 p.
artikel
89 Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: A randomized, double-blind, placebo controlled trial Cunliffe, Nigel A.
2012
30 Supplement 1 p. A36-A43
nvt p.
artikel
90 Efficacy of the oral pentavalent rotavirus vaccine in Mali Sow, Samba O.
2012
30 Supplement 1 p. A71-A78
nvt p.
artikel
91 Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer Zhu, Daming
2012
30 Supplement 1 p. 189-194
6 p.
artikel
92 Eliciting broad neutralizing antibody to HIV-1: Envelopes of different lentivirus cross immunization by prime-boost vaccination Luo, Zhenwu
2012
30 Supplement 1 p. 5316-5323
8 p.
artikel
93 Enhancement of protective immunity against intracellular bacteria using type-1 polarized dendritic cell (DC) vaccine Kono, Masato
2012
30 Supplement 1 p. 2633-2639
7 p.
artikel
94 Epidemiology of invasive pneumococcal infection among hospitalized children aged less than 5 years in Oman Awaidy, Salah Thabit Al
2012
30 Supplement 1 p. G7-G10
nvt p.
artikel
95 Epstein–Barr virus genome load is increased by therapeutic vaccination in HIV-l carriers, and further enhanced in patients with a history of symptomatic primary infection Friis, Anna M.C.
2012
30 Supplement 1 p. 6093-6098
6 p.
artikel
96 Estimating the age-specific duration of herpes zoster vaccine protection: A matter of model choice? Bilcke, Joke
2012
30 Supplement 1 p. 2795-2800
6 p.
artikel
97 Evaluation of a toolkit to introduce standing orders for influenza and pneumococcal vaccination in adults: A multimodal pilot project Nowalk, Mary Patricia
2012
30 Supplement 1 p. 5978-5982
5 p.
artikel
98 Evaluation of attenuated VSVs with mutated M or/and G proteins as vaccine vectors Fang, Xinkui
2012
30 Supplement 1 p. 1313-1321
9 p.
artikel
99 Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana Abbott, Collette
2012
30 Supplement 1 p. 2582-2587
6 p.
artikel
100 Evaluation of meningococcal serogroup C conjugate vaccine programs in Canadian children: Interim analysis Bettinger, Julie A.
2012
30 Supplement 1 p. 4023-4027
5 p.
artikel
101 Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice Sislema-Egas, Fernanda
2012
30 Supplement 1 p. 7286-7291
6 p.
artikel
102 Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac Caron, François
2012
30 Supplement 1 p. 5059-5062
4 p.
artikel
103 Factors influencing pandemic influenza vaccination of healthcare workers—A systematic review Prematunge, Chatura
2012
30 Supplement 1 p. 4733-4743
11 p.
artikel
104 Failure of the vaccination campaign against A(H1N1) influenza in pregnant women in France: Results from a national survey Blondel, Béatrice
2012
30 Supplement 1 p. 5661-5665
5 p.
artikel
105 Feasibility of a randomized controlled trial to evaluate Text Reminders for Immunization Compliance in Kids (TRICKs) Ahlers-Schmidt, Carolyn R.
2012
30 Supplement 1 p. 5305-5309
5 p.
artikel
106 Financing vaccinations – The South African experience Blecher, Mark S.
2012
30 Supplement 1 p. C79-C86
nvt p.
artikel
107 Focus and breadth of cellular immune responses elicited by a heterologous insert prime-boost vaccine regimen in rhesus monkeys Kaufman, David R.
2012
30 Supplement 1 p. 506-509
4 p.
artikel
108 GAVI Report 2012
30 Supplement 1 p. D1-D83
nvt p.
artikel
109 Genome-wide association study of antibody response to smallpox vaccine Ovsyannikova, Inna G.
2012
30 Supplement 1 p. 4182-4189
8 p.
artikel
110 Geographic differentiation of polymorphism in the Plasmodium falciparum malaria vaccine candidate gene SERA5 Tanabe, Kazuyuki
2012
30 Supplement 1 p. 1583-1593
11 p.
artikel
111 Haemophilus influenzae type b conjugate vaccines – A South African perspective Visser, Adele
2012
30 Supplement 1 p. C52-C57
nvt p.
artikel
112 Healthcare workers and H1N1 vaccination: Does having a chronic disease make a difference? Toh, Matthias Paul Han Sim
2012
30 Supplement 1 p. 1064-1070
7 p.
artikel
113 Health economics of rotavirus immunization in Vietnam: Potentials for favorable cost-effectiveness in developing countries Tu, Hong-Anh T.
2012
30 Supplement 1 p. 1521-1528
8 p.
artikel
114 Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreak Williams, Roxanne E.
2012
30 Supplement 1 p. 3147-3150
4 p.
artikel
115 Hepatitis B virus carrier rate, prevalence and susceptibility and impact of immunization program among households in the city of Taiz, Yemen Sallam, T.A.
2012
30 Supplement 1 p. 5564-5568
5 p.
artikel
116 Heteroclitic peptides enhance human immunodeficiency virus-specific CD8+ T cell responses Gladney, Krista H.
2012
30 Supplement 1 p. 6997-7004
8 p.
artikel
117 Heterologous prime-boost regimen adenovector 35-circumsporozoite protein vaccine/recombinant Bacillus Calmette-Guérin expressing the Plasmodium falciparum circumsporozoite induces enhanced long-term memory immunity in BALB/c mice Arama, Charles
2012
30 Supplement 1 p. 4040-4045
6 p.
artikel
118 HIV-1 and influenza antigens synthetically linked to IgG2a Fc elicit superior humoral responses compared to unmodified antigens in mice Zaharatos, Gerasimos J.
2011
30 Supplement 1 p. 42-50
9 p.
artikel
119 HIV vaccine candidates generate in vitro T cell response to putative epitopes in Chinese-origin rhesus macaques Liao, Qi
2012
30 Supplement 1 p. 1601-1608
8 p.
artikel
120 HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX® B/E Paris, Robert
2012
30 Supplement 1 p. 832-836
5 p.
artikel
121 Homologous whole bacterin vaccination is not able to reduce Streptococcus suis serotype 9 strain 7997 transmission among pigs or colonization Dekker, C.N.T.
2012
30 Supplement 1 p. 1379-1387
9 p.
artikel
122 Host immune response to A(H1N1)pdm09 vaccination and infection: A one-year prospective study on six cohorts of subjects Liu, Wei
2012
30 Supplement 1 p. 4785-4789
5 p.
artikel
123 How influenza vaccination policy may affect vaccine logistics Assi, Tina-Marie
2012
30 Supplement 1 p. 4517-4523
7 p.
artikel
124 Human papillomavirus, lichen sclerosus and penile cancer: A study in Belgium D’Hauwers, K.W.M.
2012
30 Supplement 1 p. 6573-6577
5 p.
artikel
125 Humoral and cellular immune response generated by different vaccine programs before and after Salmonella Enteritidis challenge in chickens Penha Filho, Rafael Antonio Casarin
2012
30 Supplement 1 p. 7637-7643
7 p.
artikel
126 Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine Tomovici, A.
2012
30 Supplement 1 p. 2647-2653
7 p.
artikel
127 Identification and characterization of Borrelia antigens as potential vaccine candidates against Lyme borreliosis Poljak, Albina
2012
30 Supplement 1 p. 4398-4406
9 p.
artikel
128 Identification of B- and T-cell epitopes from glycoprotein B of herpes simplex virus 2 and evaluation of their immunogenicity and protection efficacy Liu, Kun
2012
30 Supplement 1 p. 3034-3041
8 p.
artikel
129 Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses Spaulding, Adam R.
2012
30 Supplement 1 p. 5099-5109
11 p.
artikel
130 Immunity to tetanus and diphtheria in the UK in 2009 Wagner, Karen S.
2012
30 Supplement 1 p. 7111-7117
7 p.
artikel
131 Immunization coverage and timeliness of vaccination in Italian children with chronic diseases Pandolfi, E.
2012
30 Supplement 1 p. 5172-5178
7 p.
artikel
132 Immunization with the RrgB321 fusion protein protects mice against both high and low pilus-expressing Streptococcus pneumoniae populations Moschioni, Monica
2012
30 Supplement 1 p. 1349-1356
8 p.
artikel
133 Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice Brewoo, Joseph N.
2012
30 Supplement 1 p. 1513-1520
8 p.
artikel
134 Immunogenicity and protective efficacy of a vaxfectin-adjuvanted tetravalent dengue DNA vaccine Porter, Kevin R.
2012
30 Supplement 1 p. 336-341
6 p.
artikel
135 Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad®) in infants from 9 months of age Vesikari, Timo
2012
30 Supplement 1 p. 3082-3089
8 p.
artikel
136 Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccines in Taiwan Huang, Li-Min
2012
30 Supplement 1 p. 2054-2059
6 p.
artikel
137 Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults Hakim, Hana
2012
30 Supplement 1 p. 879-885
7 p.
artikel
138 Immunogenicity and safety of tetravalent dengue vaccine in 2–11 year-olds previously vaccinated against yellow fever: Randomized, controlled, phase II study in Piura, Peru Lanata, Claudio F.
2012
30 Supplement 1 p. 5935-5941
7 p.
artikel
139 Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age Van Der Meeren, Olivier
2012
30 Supplement 1 p. 2710-2714
5 p.
artikel
140 Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine Woolpert, Tabitha
2012
30 Supplement 1 p. 3090-3096
7 p.
artikel
141 Immunogenicity of the pentavalent rotavirus vaccine in African infants Armah, George E.
2012
30 Supplement 1 p. A86-A93
nvt p.
artikel
142 Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis Dell’Era, Laura
2012
30 Supplement 1 p. 936-940
5 p.
artikel
143 Immunological impact of an additional early measles vaccine in Gambian children: Responses to a boost at 3 years Njie-Jobe, Jainaba
2012
30 Supplement 1 p. 2543-2550
8 p.
artikel
144 Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: An overview from Kuwait Mokaddas, Eiman
2012
30 Supplement 1 p. G37-G40
nvt p.
artikel
145 Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme Ingels, Helene
2012
30 Supplement 1 p. 3944-3950
7 p.
artikel
146 Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: Systematic review and meta-analyses Yin, Jiehui Kevin
2012
30 Supplement 1 p. 3209-3222
14 p.
artikel
147 Improved neutralizing antibody response in the second season after a single dose of pandemic (H1N1) 2009 influenza vaccine in HIV-1-positive adults Kikuchi, Tadashi
2012
30 Supplement 1 p. 3819-3823
5 p.
artikel
148 Inactivated HSV-2 in MPL/alum adjuvant provides nearly complete protection against genital infection and shedding following long term challenge and rechallenge Morello, Christopher S.
2012
30 Supplement 1 p. 6541-6550
10 p.
artikel
149 Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge Cox, Josephine H.
2012
30 Supplement 1 p. 1830-1840
11 p.
artikel
150 Increasing adolescent immunization by webinar: A brief provider intervention at federally qualified health centers Moss, Jennifer L.
2012
30 Supplement 1 p. 4960-4963
4 p.
artikel
151 Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU®-Multi-HIVB, in untreated HIV-1 infected subjects Vardas, Eftyhia
2012
30 Supplement 1 p. 4046-4054
9 p.
artikel
152 Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein Loza-Rubio, Elizabeth
2012
30 Supplement 1 p. 5551-5556
6 p.
artikel
153 Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling Winkelmann, Evandro R.
2012
30 Supplement 1 p. 1465-1475
11 p.
artikel
154 Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine Song, Manki
2012
30 Supplement 1 p. 3266-3277
12 p.
artikel
155 Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis Shargh, Vahid Heravi
2012
30 Supplement 1 p. 3957-3964
8 p.
artikel
156 Lymphocyte-polarized dendritic cells are highly effective in inducing tumor-specific CTLs Berk, Erik
2012
30 Supplement 1 p. 6216-6224
9 p.
artikel
157 Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in Bangladesh Feller, Andrea J.
2012
30 Supplement 1 p. A101-A105
nvt p.
artikel
158 Maternal knowledge, attitudes and beliefs regarding gastroenteritis and rotavirus vaccine before implementing vaccination program: Which key messages in light of a new immunization program? Morin, Alyssa
2012
30 Supplement 1 p. 5921-5927
7 p.
artikel
159 Measles outbreak in Burkina Faso, 2009: A case–control study to determine risk factors and estimate vaccine effectiveness Kidd, Sarah
2012
30 Supplement 1 p. 5000-5008
9 p.
artikel
160 Measuring bovine viral diarrhea virus vaccine response: Using a commercially available ELISA as a surrogate for serum neutralization assays Gonda, M.G.
2012
30 Supplement 1 p. 6559-6563
5 p.
artikel
161 Measuring people's knowledge about vaccination: Developing a one-dimensional scale Zingg, Alexandra
2012
30 Supplement 1 p. 3771-3777
7 p.
artikel
162 Meningococcal disease from the public health policy perspective Black, Steven B.
2012
30 Supplement 1 p. B37-B39
nvt p.
artikel
163 Meningococcal vaccine development – from glycoconjugates against MenACWY to proteins against MenB – potential for broad protection against meningococcal disease Dull, Peter M.
2012
30 Supplement 1 p. B18-B25
nvt p.
artikel
164 Merozoite surface protein-1 of Plasmodium yoelii fused via an oligosaccharide moiety of cholera toxin B subunit glycoprotein expressed in yeast induced protective immunity against lethal malaria infection in mice Miyata, Takeshi
2012
30 Supplement 1 p. 948-958
11 p.
artikel
165 Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in Bangladesh Zaman, K.
2012
30 Supplement 1 p. A94-A100
nvt p.
artikel
166 Modelling the long-term persistence of neutralizing antibody in adults after one dose of live attenuated Japanese encephalitis chimeric virus vaccine Desai, Kamal
2012
30 Supplement 1 p. 2510-2515
6 p.
artikel
167 Molecular characterization of rotavirus strains detected during a clinical trial of a human rotavirus vaccine in Blantyre, Malawi Nakagomi, Toyoko
2012
30 Supplement 1 p. A140-A151
nvt p.
artikel
168 Monitoring adverse events following immunization with a new conjugate vaccine against group A meningococcus in Niger, September 2010 Chaibou, Maman S.
2012
30 Supplement 1 p. 5229-5234
6 p.
artikel
169 Monitoring of rotavirus vaccination in Morocco: Establishing the baseline burden of rotavirus disease Benhafid, Mohammed
2012
30 Supplement 1 p. 6515-6520
6 p.
artikel
170 Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentially Pissani, Franco
2012
30 Supplement 1 p. 5519-5526
8 p.
artikel
171 Mucosal vaccination increases local chemokine production attracting immune cells to the stomach mucosa of Helicobacter pylori infected mice Flach, Carl-Fredrik
2012
30 Supplement 1 p. 1636-1643
8 p.
artikel
172 Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics Tiro, Jasmin A.
2012
30 Supplement 1 p. 2368-2375
8 p.
artikel
173 Mumps: Burden of disease in France Coffinières, E.
2012
30 Supplement 1 p. 7013-7018
6 p.
artikel
174 Mycobacterium indicus pranii mediates macrophage activation through TLR2 and NOD2 in a MyD88 dependent manner Pandey, Rajeev Kumar
2012
30 Supplement 1 p. 5748-5754
7 p.
artikel
175 NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults Schmidt, Clint S.
2012
30 Supplement 1 p. 7594-7600
7 p.
artikel
176 Neonatal revaccination with Bacillus Calmette–Guérin elicits improved, early protection against Mycobacterium tuberculosis in mice Li, Wen
2012
30 Supplement 1 p. 3223-3230
8 p.
artikel
177 Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: A 10-year study Charfi, F.
2012
30 Supplement 1 p. G18-G24
nvt p.
artikel
178 Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice Nanjundappa, Roopa Hebbandi
2012
30 Supplement 1 p. 3519-3525
7 p.
artikel
179 One clinic visit for pre-exposure rabies vaccination (a preliminary one year study) Khawplod, Pakamatz
2012
30 Supplement 1 p. 2918-2920
3 p.
artikel
180 Oral administration of allergen extracts from mugwort pollen desensitizes specific allergen-induced allergy in mice Ma, Wen-Jiang
2012
30 Supplement 1 p. 1437-1444
8 p.
artikel
181 Oral administration of HPV-16 L2 displayed on Lactobacillus casei induces systematic and mucosal cross-neutralizing effects in Balb/c mice Yoon, Sun-Woo
2012
30 Supplement 1 p. 3286-3294
9 p.
artikel
182 Parental and societal values for the risks and benefits of childhood combination vaccines Gidengil, Courtney
2012
30 Supplement 1 p. 3445-3452
8 p.
artikel
183 Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: Analyses of 10 years of pertussis surveillance Nilsson, Lennart
2012
30 Supplement 1 p. 3239-3247
9 p.
artikel
184 Phase III, randomized controlled trial to evaluate lot consistency of a trivalent subunit egg-based influenza vaccine in adults Rivera, Luis
2012
30 Supplement 1 p. 5285-5292
8 p.
artikel
185 Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide Zollinger, Wendell D.
2012
30 Supplement 1 p. 712-721
10 p.
artikel
186 Phosphatidylinositol di-mannoside and derivates modulate the immune response to and efficacy of a tuberculosis protein vaccine against Mycobacterium bovis infection Parlane, Natalie A.
2012
30 Supplement 1 p. 580-588
9 p.
artikel
187 Pneumococcal serotype distribution among meningitis cases from Togo and Burkina Faso during 2007–2009 Gessner, Bradford D.
2012
30 Supplement 1 p. G41-G45
nvt p.
artikel
188 Pneumococcal vaccines WHO position paper – 2012 – Recommendations WHO Publication,
2012
30 Supplement 1 p. 4717-4718
2 p.
artikel
189 Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogotá, Colombia Benavides, Juan Alberto
2012
30 Supplement 1 p. 5886-5892
7 p.
artikel
190 Potential serotype coverage of three pneumococcal conjugate vaccines against invasive pneumococcal infection in Italian children Azzari, Chiara
2012
30 Supplement 1 p. 2701-2705
5 p.
artikel
191 Preclinical safety assessment of recombinant botulinum vaccine A/B (rBV A/B) Shearer, Jeffry D.
2012
30 Supplement 1 p. 1917-1926
10 p.
artikel
192 Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7 Henken, F.E.
2012
30 Supplement 1 p. 4259-4266
8 p.
artikel
193 Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: A review Jauneikaite, E.
2012
30 Supplement 1 p. 3503-3514
12 p.
artikel
194 Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice Zhou, Mingkui
2012
30 Supplement 1 p. 1911-1916
6 p.
artikel
195 Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3) Shen, Chun Fang
2012
30 Supplement 1 p. 300-306
7 p.
artikel
196 Prospective epidemiologic surveillance of invasive pneumococcal disease and pneumonia in children in San José, Costa Rica Arguedas, Adriano
2012
30 Supplement 1 p. 2342-2348
7 p.
artikel
197 Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: Presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection Stewart, M.
2012
30 Supplement 1 p. 2131-2139
9 p.
artikel
198 Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant Amorim, Jaime Henrique
2012
30 Supplement 1 p. 837-845
9 p.
artikel
199 Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50years Weycker, Derek
2012
30 Supplement 1 p. 5437-5444
8 p.
artikel
200 Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine Reed, Carrie
2012
30 Supplement 1 p. 1993-1998
6 p.
artikel
201 Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel Ben-Shimol, S.
2012
30 Supplement 1 p. 6600-6607
8 p.
artikel
202 Re-circulation of lymphocytes mediated by sphingosine-1-phosphate receptor-1 contributes to resistance against experimental infection with the protozoan parasite Trypanosoma cruzi Dominguez, Mariana R.
2012
30 Supplement 1 p. 2882-2891
10 p.
artikel
203 Reframing Cervical Cancer Prevention. Expanding the Field Towards Prevention of Human Papillomavirus Infections and Related Diseases Bosch, F. Xavier
2012
30 Supplement 1 p. F1-F11
nvt p.
artikel
204 Repeated dose intramuscular injection of the CIMAvax-EGF vaccine in Sprague Dawley rats induces local and systemic toxicity Mancebo, A.
2012
30 Supplement 1 p. 3329-3338
10 p.
artikel
205 Report of the ad-hoc consultation on aging and immunization for a future WHO research agenda on life-course immunization Thomas-Crusells, Judith
2012
30 Supplement 1 p. 6007-6012
6 p.
artikel
206 Reprint of: Serotyping and antibiotic susceptibility of Streptococcus pneumoniae strains isolated in Algeria from 2001 to 2010 Tali-Maamar, H.
2012
30 Supplement 1 p. G25-G31
nvt p.
artikel
207 Research priorities for global measles and rubella control and eradication Goodson, James L.
2012
30 Supplement 1 p. 4709-4716
8 p.
artikel
208 Research priorities regarding rotavirus vaccine and intussusception: A meeting summary Tate, Jacqueline E.
2012
30 Supplement 1 p. A179-A184
nvt p.
artikel
209 Respiratory viruses transmission from children to adults within a household MacIntyre, Chandini Raina
2012
30 Supplement 1 p. 3009-3014
6 p.
artikel
210 Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: Benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines Lloyd-Johnsen, C.
2012
30 Supplement 1 p. A190-A195
nvt p.
artikel
211 Revaccination with Fendrix® or HBVaxPro® results in better response rates than does revaccination with three doses of Engerix-B® in previous non-responders Hoebe, Christian J.P.A.
2012
30 Supplement 1 p. 6734-6737
4 p.
artikel
212 Risk factors associated with parents claiming personal-belief exemptions to school immunization requirements: Community and other influences on more skeptical parents in Oregon, 2006 Gaudino, James A.
2012
30 Supplement 1 p. 1132-1142
11 p.
artikel
213 Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: A randomized clinical trial in an Asian population Phua, Kong Boo
2012
30 Supplement 1 p. 4552-4557
6 p.
artikel
214 Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States Krishnarajah, Girishanthy
2012
30 Supplement 1 p. 3717-3722
6 p.
artikel
215 Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients Lertdumrongluk, Paungpaga
2012
30 Supplement 1 p. 1108-1114
7 p.
artikel
216 Safety and immunogenicity of a modified process hepatitis B vaccine in healthy neonates Minervini, Gianmaria
2012
30 Supplement 1 p. 1476-1480
5 p.
artikel
217 Safety and immunogenicity of an MF59®-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly Vesikari, Timo
2012
30 Supplement 1 p. 1388-1396
9 p.
artikel
218 Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults Seiberling, Michael
2012
30 Supplement 1 p. 7455-7460
6 p.
artikel
219 Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: A randomized, double-blind, placebo-controlled trial in Chinese males and females Li, Rongcheng
2012
30 Supplement 1 p. 4284-4291
8 p.
artikel
220 Safety and immunogenicity of 2010–2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12–59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: A PHAC/CIHR Influenza Research Network (PCIRN) study Langley, Joanne M.
2012
30 Supplement 1 p. 3389-3394
6 p.
artikel
221 Safety and immunogenicity of pneumococcal protein vaccine candidates: Monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA–pneumococcal histidine triad protein D vaccine Bologa, Monica
2012
30 Supplement 1 p. 7461-7468
8 p.
artikel
222 Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine Tambyah, Paul A.
2012
30 Supplement 1 p. 329-335
7 p.
artikel
223 Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: A randomized, dose-escalation phase 1 study in adults Gogtay, Nithya
2012
30 Supplement 1 p. 7315-7320
6 p.
artikel
224 Safety of live, attenuated oral vaccines in HIV-infected Zambian adults Banda, Rose
2012
30 Supplement 1 p. 5656-5660
5 p.
artikel
225 Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age Vermeulen, Joost N.
2012
30 Supplement 1 p. 904-910
7 p.
artikel
226 Salmonella typhi Ty21a bacterial ghost vector augments HIV-1 gp140 DNA vaccine-induced peripheral and mucosal antibody responses via TLR4 pathway Wen, Jing
2012
30 Supplement 1 p. 5733-5739
7 p.
artikel
227 School-located influenza immunization programs: Factors important to parents and students Middleman, Amy B.
2012
30 Supplement 1 p. 4993-4999
7 p.
artikel
228 Sendai virus-based RSV vaccine protects African green monkeys from RSV infection Jones, Bart G.
2012
30 Supplement 1 p. 959-968
10 p.
artikel
229 Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria Giwa, F.J.
2012
30 Supplement 1 p. 6759-6765
7 p.
artikel
230 Serotype changes in adult invasive pneumococcal infections in Portugal did not reduce the high fraction of potentially vaccine preventable infections Horácio, Andreia N.
2012
30 Supplement 1 p. 218-224
7 p.
artikel
231 Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010–2011 Tse, Alison
2012
30 Supplement 1 p. 2024-2031
8 p.
artikel
232 Simplifying complex sequence information: A PCP-consensus protein binds antibodies against all four Dengue serotypes Bowen, David M.
2012
30 Supplement 1 p. 6081-6087
7 p.
artikel
233 Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine Kanagavelu, Saravana K.
2012
30 Supplement 1 p. 691-702
12 p.
artikel
234 Stability of a formalin-inactivated Rift Valley fever vaccine: Evaluation of a vaccination campaign for cattle in Mozambique Lagerqvist, N.
2012
30 Supplement 1 p. 6534-6540
7 p.
artikel
235 Strain impact on equine herpesvirus type 1 (EHV-1) abortion models: Viral loads in fetal and placental tissues and foals Gardiner, David W.
2012
30 Supplement 1 p. 6564-6572
9 p.
artikel
236 Sustained viral load reduction in treatment-naive HCV genotype 1 infected patients after therapeutic peptide vaccination Klade, Christoph S.
2012
30 Supplement 1 p. 2943-2950
8 p.
artikel
237 The association of seasonal influenza vaccination with pandemic influenza H1N1 2009 infection Kelly, Heath
2012
30 Supplement 1 p. 2037-2038
2 p.
artikel
238 The cationic lipid, diC14 amidine, extends the adjuvant properties of aluminum salts through a TLR-4- and caspase-1-independent mechanism Wilmar, Arnaud
2012
30 Supplement 1 p. 414-424
11 p.
artikel
239 The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies Ambrose, Christopher S.
2012
30 Supplement 1 p. 886-892
7 p.
artikel
240 The extradomain A of fibronectin (EDA) combined with poly(I:C) enhances the immune response to HIV-1 p24 protein and the protection against recombinant Listeria monocytogenes-Gag infection in the mouse model San Román, Beatriz
2012
30 Supplement 1 p. 2564-2569
6 p.
artikel
241 The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): Results of two Phase I studies Harro, Clayton D.
2012
30 Supplement 1 p. 1729-1736
8 p.
artikel
242 The impact of making vaccines thermostable in Niger's vaccine supply chain Lee, Bruce Y.
2012
30 Supplement 1 p. 5637-5643
7 p.
artikel
243 The pediatric vaccine stockpiling problem Truong, Van-Anh
2012
30 Supplement 1 p. 6175-6179
5 p.
artikel
244 The potential economic value of a Staphylococcus aureus vaccine among hemodialysis patients Song, Yeohan
2012
30 Supplement 1 p. 3675-3682
8 p.
artikel
245 The presence of viral subpopulations in an infectious bronchitis virus vaccine with differing pathogenicity – A preliminary study Hewson, Kylie A.
2012
30 Supplement 1 p. 4190-4199
10 p.
artikel
246 The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: A capture–recapture analysis Huang, Wan-Ting
2012
30 Supplement 1 p. 2168-2172
5 p.
artikel
247 The role of nasal IgA in children vaccinated with live attenuated influenza vaccine Ambrose, Christopher S.
2012
30 Supplement 1 p. 6794-6801
8 p.
artikel
248 The structure of HBsAg particles is not modified upon their adsorption on aluminium hydroxide gel Greiner, Vanille J.
2012
30 Supplement 1 p. 5240-5245
6 p.
artikel
249 The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines McElhaney, Janet E.
2012
30 Supplement 1 p. 2060-2067
8 p.
artikel
250 Thymosin-alpha 1 (Zadaxin™) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria™) in hemodialyzed patients: A pilot study Carraro, G.
2012
30 Supplement 1 p. 1170-1180
11 p.
artikel
251 Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis Cui, Xia
2012
30 Supplement 1 p. 2282-2287
6 p.
artikel
252 Transcutaneous immunization with Intercell's vaccine delivery system Seid Jr., Robert C.
2012
30 Supplement 1 p. 4349-4354
6 p.
artikel
253 Transfer of the ability of HIV-1 Tat to raise an adjuvant-free humoral immune response to unrelated antigens Gadzinski, Adeline
2012
30 Supplement 1 p. 2859-2868
10 p.
artikel
254 Transmission of a live Eimeria acervulina vaccine strain and response to infection in vaccinated and contact-vaccinated broilers Velkers, Francisca C.
2012
30 Supplement 1 p. 322-328
7 p.
artikel
255 Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoprotein Dey, Antu K.
2012
30 Supplement 1 p. 2749-2759
11 p.
artikel
256 Use of human MonoMac6 cells for development of in vitro assay predictive of adjuvant safety in vivo Zaitseva, Marina
2012
30 Supplement 1 p. 4859-4865
7 p.
artikel
257 Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period De Serres, Gaston
2012
30 Supplement 1 p. 4067-4072
6 p.
artikel
258 Use of the 13-valent conjugate vaccine has the potential to eliminate pilus carrying isolates as causes of invasive pneumococcal disease Aguiar, Sandra I.
2012
30 Supplement 1 p. 5487-5490
4 p.
artikel
259 UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV Jones, Bart G.
2012
30 Supplement 1 p. 3188-3195
8 p.
artikel
260 Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults Potsch, D.V.
2012
30 Supplement 1 p. 5973-5977
5 p.
artikel
261 Vaccination and acute phase mediator production in chickens challenged with low pathogenic avian influenza virus; novel markers for vaccine efficacy? Sylte, Matthew J.
2012
30 Supplement 1 p. 3097-3105
9 p.
artikel
262 Vaccination and risk of type 1 diabetes mellitus in active component U.S. Military, 2002–2008 Duderstadt, Susan K.
2012
30 Supplement 1 p. 813-819
7 p.
artikel
263 Vaccination of chickens with Salmonella Pathogenicity Island (SPI) 1 and SPI2 defective mutants of Salmonella enterica serovar Enteritidis Matulova, M.
2012
30 Supplement 1 p. 2090-2097
8 p.
artikel
264 Vaccination of piglets at 1 week of age with an inactivated Mycoplasma hyopneumoniae vaccine reduces lung lesions and improves average daily gain in body weight Wilson, Stephen
2012
30 Supplement 1 p. 7625-7629
5 p.
artikel
265 Vaccination with BM86, subolesin and akirin protective antigens for the control of tick infestations in white tailed deer and red deer Carreón, Diana
2012
30 Supplement 1 p. 273-279
7 p.
artikel
266 Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis Zhang, L.
2012
30 Supplement 1 p. 2301-2308
8 p.
artikel
267 Vaccination with 3-dose paediatric rotavirus vaccine (RotaTeq®): Impact on the timeliness of uptake of the primary course of DTPa vaccine Wendy, Bissinger
2012
30 Supplement 1 p. 5293-5297
5 p.
artikel
268 Vaccination with Haemophilus influenzae type b conjugate vaccine reduces bacterial meningitis in Morocco Braikat, Mohamed
2012
30 Supplement 1 p. 2594-2599
6 p.
artikel
269 Vaccination with the recombinant chimeric antigen recNcMIC3-1-R induces a non-protective Th2-type immune response in the pregnant mouse model for N. caninum infection Monney, Thierry
2012
30 Supplement 1 p. 6588-6594
7 p.
artikel
270 Vaccine and Immunization Surveillance in Ontario (VISION) – Using linked health administrative databases to monitor vaccine safety Wilson, Kumanan
2012
30 Supplement 1 p. 6115-6120
6 p.
artikel
271 Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques Bialuk, Izabela
2011
30 Supplement 1 p. 78-94
17 p.
artikel
                             271 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland